Clinical outcome of older patients with acute coronary syndrome over the last three decades

Age and Ageing

Volumn 35, Issue 3, 2006, Pages 280-285

  Tang, Eng Wei ^a,b   Wong, Cheuk Kit ^a,b   Restieaux, Norma J ^a,b   Herbison, Peter ^a,b   Williams, Micheal J A ^a,b   Kay, Patrick ^a,b   Wilkins, Gerard T ^a,b  

^a DUNEDIN HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Acute coronary syndrome; Cardiovascular outcome; Changing demography; Elderly

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; DATA ANALYSIS; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEW ZEALAND; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646178970     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afj079     Document Type: Article

References (22)

1. Capewell S, Morrison CE, McMurray J. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 380-6.
2. Capewell S, Beaglehole R, Seddon M et al. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000; 102: 1511-6.
3. McGovern PG, Pankow JS, Shahar E et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care and risk factors. N Engl J Med 1996; 334: 884-90.
4. Reitsma JB, Dalstra JA, Bonsel GJ et al. Cardiovascular disease in the Netherlands, 1975 to 1995: Decline in mortality, but increasing numbers of patients with chronic conditions. Heart 1999; 82: 52-6.
5. Levy D, Thorn TJ. Death rates from coronary disease - progress and a puzzling paradox. N Engl J Med 1998; 339: 915-7.
6. Hunink MG, Goldman L, Tosteson AN et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. J Am Med Assoc 1997; 227: 535-42.
7. Shepherd J. International comparison of awareness and attitudes towards coronary risk factor reduction: The HELP study. Heart European Leaders Panel. Atherosclerosis 1998; 137 Suppl: S117-23.
8. Rosamond WD, Chambless LE, Folsom AR et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-7.
9. Stewart RA, Robertson MC, Wilkins GT et al. Association between activity at onset of symptoms and outcome of acute myocardial infarction. J Am Coll Cardiol 1997; 29: 250-3.
10. Stewart RA, Robertson MC, Low CJ et al. Differences in easily recognised coronary risk factors by age at first myocardial infarction. NZ Med J 1997; 110: 339-40.
11. de Vreede JJ, Gorgels AP, Verstraaten GM et al. Did prognosis after myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 1991; 18: 698-706.
12. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999. The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
13. Thiemann DR, Coresh J, Schulman SP et al. Lack of benefit for intravenous thrombolysis in patients with acute myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-46.
14. Angeja BG, Rundle AC, Gurwitz JH et al. Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. Am J Cardiol 2001; 87: 627-30.
15. Stenestrand U, Wallentin L; Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: One-year follow-up of a large prospective cohort. Arch Intern Med 2003; 163: 965-71.
16. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
17. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: The Expert Panel. Arch Intern Med 1988; 148: 36-69.
18. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel II). Circulation 1994; 89: 1333-445.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-97.
20. Aylward PE, Wilcox RG, Horgan JH et al. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomised trial. Ann Intern Med 1996; 125: 891-900.
21. Goldberg RJ, Yarzebski J, Lessard D et al. Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction. The Worcester Heart Attack Study. Arch Intern Med 2000; 160: 3217-23.
22. McSweeney JC, Cody M, O'Sullivan P et al. Women's early warning symptoms of acute myocardial infarction. Circulation 2003; 108: 2619-23.